405 related articles for article (PubMed ID: 25263788)
1. Resveratrol prevents social deficits in animal model of autism induced by valproic acid.
Bambini-Junior V; Zanatta G; Della Flora Nunes G; Mueller de Melo G; Michels M; Fontes-Dutra M; Nogueira Freire V; Riesgo R; Gottfried C
Neurosci Lett; 2014 Nov; 583():176-81. PubMed ID: 25263788
[TBL] [Abstract][Full Text] [Related]
2. Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.
Hirsch MM; Deckmann I; Fontes-Dutra M; Bauer-Negrini G; Della-Flora Nunes G; Nunes W; Rabelo B; Riesgo R; Margis R; Bambini-Junior V; Gottfried C
Food Chem Toxicol; 2018 May; 115():336-343. PubMed ID: 29510222
[TBL] [Abstract][Full Text] [Related]
3. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters.
Bambini-Junior V; Rodrigues L; Behr GA; Moreira JC; Riesgo R; Gottfried C
Brain Res; 2011 Aug; 1408():8-16. PubMed ID: 21767826
[TBL] [Abstract][Full Text] [Related]
4. Sex dependent alterations of resveratrol on social behaviors and nociceptive reactivity in VPA-induced autistic-like model in rats.
Juybari KB; Sepehri G; Meymandi MS; Vakili Shahrbabaki SS; Moslemizadeh A; Saeedi N; Aminzadeh A; Nozari M; Khaksari M; Haghpanah T; Bashiri H
Neurotoxicol Teratol; 2020; 81():106905. PubMed ID: 32534151
[TBL] [Abstract][Full Text] [Related]
5. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
Schneider T; Przewłocki R
Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991
[TBL] [Abstract][Full Text] [Related]
6. In utero exposure to valproic acid and autism--a current review of clinical and animal studies.
Roullet FI; Lai JK; Foster JA
Neurotoxicol Teratol; 2013; 36():47-56. PubMed ID: 23395807
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.
Schneider T; Roman A; Basta-Kaim A; Kubera M; Budziszewska B; Schneider K; Przewłocki R
Psychoneuroendocrinology; 2008 Jul; 33(6):728-40. PubMed ID: 18396377
[TBL] [Abstract][Full Text] [Related]
8. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
9. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.
Kim KC; Kim P; Go HS; Choi CS; Park JH; Kim HJ; Jeon SJ; Dela Pena IC; Han SH; Cheong JH; Ryu JH; Shin CY
J Neurochem; 2013 Mar; 124(6):832-43. PubMed ID: 23311691
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism.
Hara Y; Ago Y; Higuchi M; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Horm Behav; 2017 Nov; 96():130-136. PubMed ID: 28942000
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autism.
Santos-Terra J; Deckmann I; Carello-Collar G; Nunes GD; Bauer-Negrini G; Schwingel GB; Fontes-Dutra M; Riesgo R; Gottfried C
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456893
[TBL] [Abstract][Full Text] [Related]
12. Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism.
Sabers A; Bertelsen FC; Scheel-Krüger J; Nyengaard JR; Møller A
Neurosci Lett; 2014 Sep; 580():12-6. PubMed ID: 25079904
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
Takuma K; Hara Y; Kataoka S; Kawanai T; Maeda Y; Watanabe R; Takano E; Hayata-Takano A; Hashimoto H; Ago Y; Matsuda T
Pharmacol Biochem Behav; 2014 Nov; 126():43-9. PubMed ID: 25240644
[TBL] [Abstract][Full Text] [Related]
14. Ameliorating age-dependent effects of resveratrol on VPA-induced social impairments and anxiety-like behaviors in a rat model of neurodevelopmental disorder.
Shahrbabaki SSV; Moslemizadeh A; Amiresmaili S; Tezerji SS; Juybari KB; Sepehri G; Shamsi Meymandi M; Bashiri H
Neurotoxicology; 2023 May; 96():154-165. PubMed ID: 36933665
[TBL] [Abstract][Full Text] [Related]
15. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
Baronio D; Castro K; Gonchoroski T; de Melo GM; Nunes GD; Bambini-Junior V; Gottfried C; Riesgo R
PLoS One; 2015; 10(1):e0116363. PubMed ID: 25560049
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol prevents long-term structural hippocampal alterations and modulates interneuron organization in an animal model of ASD.
Santos-Terra J; Deckmann I; Schwingel GB; Paz AVC; Gama CS; Bambini-Junior V; Fontes-Dutra M; Gottfried C
Brain Res; 2021 Oct; 1768():147593. PubMed ID: 34331907
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid.
Fontes-Dutra M; Santos-Terra J; Deckmann I; Brum Schwingel G; Della-Flora Nunes G; Hirsch MM; Bauer-Negrini G; Riesgo RS; Bambini-Júnior V; Hedin-Pereira C; Gottfried C
Front Synaptic Neurosci; 2018; 10():9. PubMed ID: 29872390
[TBL] [Abstract][Full Text] [Related]
18. Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism.
Hirsch MM; Deckmann I; Santos-Terra J; Staevie GZ; Fontes-Dutra M; Carello-Collar G; Körbes-Rockenbach M; Brum Schwingel G; Bauer-Negrini G; Rabelo B; Gonçalves MCB; Corrêa-Velloso J; Naaldijk Y; Castillo ARG; Schneider T; Bambini-Junior V; Ulrich H; Gottfried C
Neuropharmacology; 2020 May; 167():107930. PubMed ID: 31904357
[TBL] [Abstract][Full Text] [Related]
19. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
[TBL] [Abstract][Full Text] [Related]
20. The GABAB receptor agonist STX209 reverses the autism‑like behaviour in an animal model of autism induced by prenatal exposure to valproic acid.
Jiang S; Xiao L; Sun Y; He M; Gao C; Zhu C; Chang H; Ding J; Li W; Wang Y; Sun T; Wang F
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35244195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
